👩🍳 How we use AI at Tech in Asia, thoughtfully and responsibly.
🧔♂️ A friendly human may check it before it goes live. More news here
🧔♂️ A friendly human may check it before it goes live. More news here
UAE healthtech firm extends pre-series A funding to $7m
BioSapien, a United Arab Emirates-based healthtech firm, has extended its pre-series A funding round to US$7 million.
New investors, including Golden Gate Ventures, have contributed from its MENA Fund.
The company, founded in 2018 by Khatija Ali, raised US$5.5 million in December with support from Global Ventures and Dara Holdings.
The new funds will facilitate clinical trials for BioSapien’s 3D-printed drug delivery platform, which is scheduled to begin in Abu Dhabi in the second quarter of 2025.
BioSapien intends to use the funds to advance its goal of treating over one million patients globally by 2035.
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.